Presenting a new paradigm for incurable dental diseases for the first time through reactivation of poorly functioning or aged tooth cells

·  Completion of dental specialized technology platform Dentopine by utilizing HysensBio peptide, the world’s first developed dentin regenerative peptide

·  Development of treatment for dentin hypersensitivity, dental caries and periodontal disease by developing prescription drugs that regenerate physiologic dentin

·  Completion of technology for incurable dental diseases by developing veterinary dental medicine and alveolar bone regenerative technology

· Developing various treatment areas through innovative R&D

· Research on safety, efficacy, and mechanism of action (MoA) is ongoing through non-clinical studies